SEE
53
3
CHD
54
4
DE
42
3
CMA
61
-3
NEE
54
7
WMB
68
2
ILMN
32
-9
CAT
59
-2
CB
57
2
DNB
74
-6
KHC
9
-4
IFF
47
-4
AMZN
61
-5
ACN
47
-5
EA
60
-5
KSS
39
-7
HSIC
45
5
INTU
58
-3
SJM
9
-5
VMC
53
-4
SEE
53
3
CHD
54
4
DE
42
3
CMA
61
-3
NEE
54
7
WMB
68
2
ILMN
32
-9
CAT
59
-2
CB
57
2
DNB
74
-6
KHC
9
-4
IFF
47
-4
AMZN
61
-5
ACN
47
-5
EA
60
-5
KSS
39
-7
HSIC
45
5
INTU
58
-3
SJM
9
-5
VMC
53
-4
Financhill
Back

Highland Opportunities and Income Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
44

HFRO
Highland Opportunities and Income Fund

Last Price:
5.43
Seasonality Move:
0.2%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
44
Highland Opportunities and Income Fund (HFRO) is a Sell

Is Highland Opportunities and Income Fund a Buy, Sell or Hold?

  • The current Highland Opportunities and Income Fund [HFRO] share price is $5.43. The Score for HFRO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • HFRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HFRO Stock Price Chart

What is Highland Opportunities and Income Fund's stock price today?

  • The Highland Opportunities and Income Fund share price today is $5.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HFRO is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

HFRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 28.33 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.52 - 5.8) Sell
Bollinger Bands (100): (5.75 - 6.23) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

HFRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.51 Sell
20-day SMA: 5.61 Sell
50-day SMA: 5.92 Sell
200-day SMA: 6.22 Sell
8-day EMA: 5.5 Sell
20-day EMA: 5.62 Sell
50-day EMA: 5.81 Sell
200-day EMA: 6.37 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Highland Opportunities and Income Fund Earnings Growth & HFRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Highland Opportunities and Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):